Order Center
 
Life Science

Antibodies
Automation
Cancer Research
Cell Culture
Cell Signaling and Neuroscience
Custom Synthesis
Drug Discovery
Epigenetics
Functional Genomics and RNAi
Synthetic RNA
MISSION What's New
Key resources
RNAi Learning Center
miRNA
shRNA
siRNA
Metabolomics
Molecular Biology
Neuroscience
Nutrition Research
Obesity Research
Peptides and Proteins
Plant Biotechnology
Proteomics and Protein Expr.
Stable Isotopes
Stem Cell Biology
Your Favorite Gene - Search
Life Science Innovations
PathFinder

 TargeTron® Vector pACD4K-C-loxP

Functional Genomics & RNAi
 

The TargeTron Vector pACD4K-C-loxP (T2826) is a linerized, E. coli expression vector to be used in conjunction with the TargeTron Gene Knockout System (TA0100). This vector differs from the original pACD4K-C vector in that it has loxP sites flanking each end of the kanamycin ORF allowing for multiple, site-specific knockouts in the same bacterial chromosome. After the initial knockout is generated, the kanamycin resistance marker used to select for insertions can be removed via Cre-loxP mediated recombination.1,2 After removal of the kanamycin resistance marker, sequential "targetron" insertions can be generated.3

pACD4K-C-loxP Vector Sequence (7.80 Kb txt file)

Technical Bulletin

Vector Map

Data

Ordering Information

TargeTron Vector

References

  1. Abremski, K. et al., J. Biol. Chem., 261 (1), 391-396 (1986)
  2. Hartung, M. et al., J. Biol. Chem., 273 (36), 22884-22891 (1998)
  3. Zhong, J. et al., Nucleic Acids Res., 31 (6), 1656-1664 (2003)


Related Products
TargeTron Gene Knockout System




TargeTron® Vector pACD4K-C-loxP Vector Map


Feature Position
p15A ori 585-1497
T7 promoter 1741-1762
5' exon (IBS) 1802-1826
Intron RNA 1827-4182
EBS2 (exon binding sequence 2) 2049-2053
EBS1d 2102-2111
5' loxP site 2523-2555
Kanamycin RAM 2556-3923
td group I intron RAM 2853-3245
3' loxP site 3924-3957
3' exon 4183-4192
LtrA ORF 4429-6228

back to top


TargeTron® Vector pACD4K-C-loxP Data


PCR was performed using lacZ gene specific primers. Lanes 1-2 are duplicate reactions using wild-type BL21(DE3) as template. Lanes 3-4 are duplicate reactions using the lacZ1062a intron insertional mutant containing the kanamycin marker (i.e., before Cre recombination). Lanes 5-6 are duplicate reactions of the same lacZ1062a intron insertional mutant strain that was transformed with a plasmid expressing Cre recombinase (i.e., after Cre-loxP recombination). The removal of the kanamycin resistance marker (Lanes 5-6) is evident by the ~1.0 kb reduction in amplicon size after Cre-loxP recombination.




TargeTron is a registered trademark of InGex, LLC.



back to top
TargeTron® Gene Knockout System




Site Use Terms Terms and Conditions of Sale Privacy Business Development Contact Us
Copyrights © 2008 Sigma-Aldrich Co. All Rights Reserved.
Reproduction of any materials from the site is strictly forbidden without permission.
Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc.